Stay updated on NAC Therapy in ME/CFS Clinical Trial
Sign up to get notified when there's something new on the NAC Therapy in ME/CFS Clinical Trial page.

Latest updates to the NAC Therapy in ME/CFS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision label changed from v3.6.3 to v3.6.4, indicating a new build of the page rather than changes to the study data.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 on the page. This reflects a minor update to the site's revision history without affecting study content or user interactions.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study's recruitment status is updated to Active, not recruiting and No longer looking for participants, and contact information fields are removed. New study documents are added, including an Informed Consent Form (PDF, revision v3.6.2) and related materials, along with a Primary Completion date of 2027-04-30.SummaryDifference2%

- Check57 days agoChange DetectedThe page now includes new user guidance sections—Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study—along with a standardized Intervention/Treatment heading and an updated revision tag from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check64 days agoChange DetectedThe page's revision was updated from v3.5.4 to v3.5.5, indicating a new build of the record. This likely reflects minor updates or fixes to the page rather than changes to the study data.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This signals a minor update to the page version.SummaryDifference0.1%

Stay in the know with updates to NAC Therapy in ME/CFS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NAC Therapy in ME/CFS Clinical Trial page.